SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently seeing a massive surge fueled by sympathy momentum from Intel's strong earnings report and bullish analyst upgrades that highlight rising CPU demand in AI data centers. While the community remains deeply polarized between long-term bulls targeting higher valuations and skeptics warning of an overextended bubble, traders are actively debating the sustainability of this rapid upward move.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is experiencing significant volatility as market sentiment fluctuates between excitement over its role in global AI infrastructure and frustration over recent stagnant price action compared to semiconductor peers. While community members are heavily debating the sustainability of the AI rally and the implications of broader sector rotation, many remain focused on the stock's potential for a breakout based on its dominant position in data center expansion and upcoming earnings.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing significant market momentum driven by a strong earnings beat and positive forward guidance, fueling widespread discussion about a potential CPU renaissance in AI-driven data centers. While the community is actively debating the sustainability of this rapid re-rating and debating whether to take profits or hold for long-term growth, analysts are rapidly revising their price targets in response to the surge.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing intense buying activity and high volume as investors react to confirmed purchase orders linked to Marvell Technologies and ongoing speculation about partnerships with major cloud hyperscalers. Community sentiment is overwhelmingly bullish, with many traders framing the recent price action as a structural breakout that is forcing short sellers to cover their positions.

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz is trending following a significant jury verdict awarding the company hundreds of millions in damages against rival Papaya Gaming for the use of bots. While the community is actively debating the stock's potential for a massive squeeze or further volatility, investors remain focused on the potential for additional disgorgement rulings and the company's improved financial outlook.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is seeing intense investor activity driven by a parabolic rally in the semiconductor sector, fueled by massive AI-driven infrastructure demand and consistent momentum that has kept the ETF trending higher. While many in the community are celebrating record gains and speculative targets, others are actively debating whether this represents a sustainable super-cycle or a dangerous bubble approaching a blow-off top.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares is seeing explosive volume and intense debate as traders weigh the sector's relentless melt-up against potential signs of an overextended AI-driven bubble. While many investors are actively seeking entries into this leveraged inverse play, the community remains polarized between those calling for a historic blow-off top and those cautioning against the risks of volatility decay.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The semiconductor sector remains a central point of market debate, with the SMH ETF showing significant volatility as traders weigh record-breaking momentum against concerns over AI-driven capex sustainability and geopolitical bottlenecks. Community members are actively split between capitalizing on the sector's parabolic rise and positioning for a potential correction, driven by intense speculation on whether recent gains represent structural growth or a speculative bubble.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is surging due to positive financial results and guidance that emphasize a strategic pivot into AI-driven data center infrastructure. The community is actively debating the sustainability of this sharp rally, with many traders discussing the potential for a continued momentum trade versus concerns that the stock may be overextended.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is capturing significant attention as investors weigh the potential of its oral Wegovy pill against Eli Lilly's recent market entry, with the company's new AI partnership with OpenAI further fueling hopes for accelerated drug discovery. Despite recent share price volatility, the community is actively debating the stock's valuation, dividend yield, and the long-term impact of evolving GLP-1 competitive dynamics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Strength Seen in Catalyst (CPRX): Can Its 6.7% Jump Turn into More Strength?

Catalyst (CPRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Catalyst Pharmaceuticals (NASDAQ:CPRX) Sets New 1-Year High - Here's What Happened

Catalyst Pharmaceuticals (NASDAQ:CPRX) Reaches New 52-Week High - What's Next...

SNY & REGN's Dupixent Wins FDA Nod for Pediatric Use in Urticaria 

Sanofi wins FDA nod to expand Dupixent in kids aged 2-11 years, marking the first biologic for young patients with uncontrolled CSU.

SNY's Tzield Gets FDA Nod for Kids, Sarclisa SC BLA Faces Delay

Sanofi wins FDA nod to expand Tzield's use to younger patients, while Sarclisa SC review faces delay with a new decision date set for July 2026.

INBX Stock Up on Upbeat Clinical Update From Colorectal Cancer Study

Inhibrx Biosciences stock surges after phase I/II CRC data of ozekibart show strong response rates and durable benefit, alongside a new FDA filing for ozekibart in chondrosarcoma.

AMRX Announces Kashiv BioSciences Buyout, Solid Q1 Preliminary Results

Amneal's deal to buy Kashiv for up to $1.10B aids biosimilar push. The company posts strong preliminary Q1 results and raises 2026 EPS guidance.

European Commission Approves MRNA's COVID-19-Influenza Combo Shot

Moderna wins EU approval for its COVID-19-flu combo shot mCombriax, backed by strong phase III data showing superior immune response vs standalone vaccines.

NVO's Etavopivat Hits Key Goals in Phase III Sickle Cell Disease Study

Novo Nordisk's etavopivat meets phase III goals, cutting VOCs and boosting haemoglobin in sickle cell disease, with data backing a favorable safety profile.

LLY to Buy Oncology Biotech Kelonia Therapeutics for $7 Billion

Eli Lilly is set to acquire Kelonia Therapeutics in a $7B deal, boosting its genetic medicine platform with a novel in vivo CAR-T therapy for cancer.

Agios Stock Sinks 23% as NVO's PKR Activator Meets Goal in SCD Study

AGIO shares plunge after Novo Nordisk's strong sickle cell data raised doubts about mitapivat's competitiveness and approval prospects.

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.45	--	--	N/A
Q4 '25	$0.34	$0.41	19.19%	BEAT
Q3 '25	$0.33	$0.42	26.51%	BEAT
Q2 '25	$0.39	$0.41	4.59%	BEAT
Q1 '25	$0.34	$0.45	32.35%	BEAT

CPRX
Catalyst Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest CPRX News

CPRXCatalyst Pharmaceuticals Inc